{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS Sponsor Protocol","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-open-label-dose-escalation-and-dose-expansion-study-for-lncb74-a-b7-h4-targeted-antibody-drug-conjugate-as-monotherapy-in-participants-with-advanced-solid-tumors-sponsor-protocol\/#breadcrumbitem"}]}